Kiora Pharmaceuticals Secures U.S. Composition-of-Matter Patent Expanding Protection of Its ...
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that the U.S. Patent and Trademark Office has issued a composition ...
Kiora Pharmaceuticals secures new patent for KIO-104
ENCINITAS, CA - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), a small-cap biotech firm with a market capitalization of $10.47 million and strong financial health according to InvestingPro analysis, has ...
Anavex projects EMA feedback on Alzheimer's drug by year-end 2025
Bishop asked about upcoming events. Missling outlined the anticipated schizophrenia trial readout for ANAVEX 3-71 in the first half of 2025, the detailed ATTENTION-AD data presentation in April, and ...